Home › GERD › NCT06280664

Efficacy Of Hiatal Closure For GERD

Who can join

Ages 18 to 50 · All sexes

Inclusion Criteria:

* Age 18 - 50 years
* Able to provide informed consent
* BMI \<30
* Hiatal defect \<4cm on esophagram
* pH testing requirement: pH \<4 for \>5.5%
* Surgical candidate for hiatal closure only

Exclusion Criteria:

* Vulnerable subjects (children, prisoners, pregnant women) will be excluded.

About the study

The purpose of this protocol is to study the efficacy of hiatal closure for early GERD disease. The study team hypothesizes that hiatal closure for early GERD disease is an efficacious treatment of GERD.

Sponsor: University of Chicago · Participants: 40 · Started: Oct 2, 2020

Contact the study team

• Yalini Vigneswaran, MD · Phone: 773-702-6337

Official record on ClinicalTrials.gov — NCT06280664

Locations in the U.S.

Conditions

• GERD

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.